Literature DB >> 1522835

Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects.

.   

Abstract

Spina bifida and anencephaly are common and serious birth defects. Available evidence indicates that 0.4 mg (400 micrograms) per day of folic acid, one of the B vitamins, will reduce the number of cases of neural tube defects (NTDs). In order to reduce the frequency of NTDs and their resulting disability, the United States Public Health Service recommends that: All women of childbearing age in the United States who are capable of becoming pregnant should consume 0.4 mg of folic acid per day for the purpose of reducing their risk of having a pregnancy affected with spina bifida or other NTDs. Because the effects of higher intakes are not well known but include complicating the diagnosis of vitamin B12 deficiency, care should be taken to keep total folate consumption at less than 1 mg per day, except under the supervision of a physician. Women who have had a prior NTD-affected pregnancy are at high risk of having a subsequent affected pregnancy. When these women are planning to become pregnant, they should consult their physicians for advice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522835

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  208 in total

1.  Public health 101 for informaticians.

Authors:  D Koo; P O'Carroll; M LaVenture
Journal:  J Am Med Inform Assoc       Date:  2001 Nov-Dec       Impact factor: 4.497

2.  Impact of folic acid intake during pregnancy on genomic imprinting of IGF2/H19 and 1-carbon metabolism.

Authors:  Aggeliki Tserga; Alexandra M Binder; Karin B Michels
Journal:  FASEB J       Date:  2017-08-04       Impact factor: 5.191

Review 3.  Effects and safety of periconceptional folate supplementation for preventing birth defects.

Authors:  Luz Maria De-Regil; Ana C Fernández-Gaxiola; Therese Dowswell; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

4.  Neural tube defects and periconceptional folic acid.

Authors:  Rezan A Kadir; Demetrios L Economides
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

5.  Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study.

Authors:  Rebecca J Schmidt; Daniel J Tancredi; Sally Ozonoff; Robin L Hansen; Jaana Hartiala; Hooman Allayee; Linda C Schmidt; Flora Tassone; Irva Hertz-Picciotto
Journal:  Am J Clin Nutr       Date:  2012-05-30       Impact factor: 7.045

6.  Maternal tea consumption during early pregnancy and the risk of spina bifida.

Authors:  Mahsa M Yazdy; Sarah C Tinker; Allen A Mitchell; Laurie A Demmer; Martha M Werler
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-05-29

Review 7.  Opposing roles of folate in prostate cancer.

Authors:  Kevin J Rycyna; Dean J Bacich; Denise S O'Keefe
Journal:  Urology       Date:  2013-08-28       Impact factor: 2.649

8.  Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects.

Authors:  Adolfo Correa; Suzanne M Gilboa; Lorenzo D Botto; Cynthia A Moore; Charlotte A Hobbs; Mario A Cleves; Tiffany J Riehle-Colarusso; D Kim Waller; E Albert Reece
Journal:  Am J Obstet Gynecol       Date:  2011-12-27       Impact factor: 8.661

9.  Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States.

Authors:  Bridget S Mosley; Mario A Cleves; Anna Maria Siega-Riz; Gary M Shaw; Mark A Canfield; D Kim Waller; Martha M Werler; Charlotte A Hobbs
Journal:  Am J Epidemiol       Date:  2008-10-25       Impact factor: 4.897

10.  Chlorella pyrenoidosa supplementation reduces the risk of anemia, proteinuria and edema in pregnant women.

Authors:  Shiro Nakano; Hideo Takekoshi; Masuo Nakano
Journal:  Plant Foods Hum Nutr       Date:  2010-03       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.